All articles tagged with #e cigarettes
The FDA implemented a policy shift to allow more e-cigarettes and nicotine pouches onto the U.S. market, a move that regulators say blindsided staff and critics who warn it could weaken oversight and public health protections, potentially increasing youth access to vaping products.
The FDA granted its first authorization for fruit-flavored e-cigarettes intended for adults who want to quit or cut back on smoking, marking a notable policy shift tied to the Trump administration; the Mango, Blueberry and two menthol varieties from Glas Inc. will require government ID age-verification and a Bluetooth connection to the user's device, a setup aimed at reducing youth access, while health groups warn that flavors still drive teen vaping and critics question whether the risk–reduction rationale outweighs youth appeal.
The FDA granted the first authorization for fruit-flavored disposable e-cigarettes intended for adults seeking to quit or reduce smoking. Glas Inc. will market mango, blueberry and two menthol variants, with age-verification via government ID and Bluetooth linking to a verified user’s phone. The agency stressed this is not an endorsement and emphasizes monitoring for youth access, reflecting ongoing flavor-policy tensions even as teen vaping declines.
The FDA granted the first authorization for fruit-flavored e-cigarettes intended for adult smokers, a major policy shift pressured by the vaping industry during the Trump era. The Glas Inc. devices come in mango, blueberry and two menthol varieties and require age verification via government ID and Bluetooth linkage to the user’s phone. The agency says the products are for adults looking to quit or cut back on cigarettes, not an endorsement, and will monitor marketing and usage closely, with the possibility of suspension if youth uptake increases or benefits no longer outweigh risks. The move contrasts with Biden-era crackdowns that denied many flavor applications, and it comes amid ongoing debate about flavors fueling teen vaping despite declining youth usage.
The FDA has authorized the first fruit-flavored e-cigarette for sale to adults, a milestone in the agency's premarket tobacco product approvals that underscores balancing adult access with ongoing efforts to curb youth vaping.
A qualitative review of vaping literature concludes nicotine-based e-cigarettes are likely carcinogenic, citing DNA damage and tissue inflammation observed in lab, animal, and case studies; however, the exact cancer risk cannot be quantified yet, and experts remain divided on how this risk compares to smoking.
Reaction to a Carcinogenesis paper on the carcinogenicity of e-cigarettes drew divided expert opinion. Some scientists say the review wrongly treats any detected trace as cancer-causing and note nicotine itself is not a carcinogen, stressing that vaping exposes far fewer tobacco-related carcinogens than smoking. Others criticize its lack of systematic methodology, opaque data handling, and selective citing, arguing it does not prove vaping causes cancer or quantify risk. Overall, experts agree vaping involves harm but remains a less harmful alternative to smoking for those who switch, and there is no robust evidence that vaping equals the cancer risk of combustion cigarettes.
A comprehensive review of more than 100 studies published since 2017 finds that vaping is likely to cause lung and oral cancers, supported by human biomarkers, animal studies, and lab data on vape liquids. Long-term, population-level risk cannot yet be quantified, but the evidence is strong enough to urge caution and stricter regulation, especially given higher risks for dual users and youths who start vaping.
A December 2025 study in Environmental Science & Technology finds that aerosols from e-cigarettes can become chemically reactive after lingering in indoor air, forming organic hydroperoxides and radicals; ultrafine particles concentrate redox-active metals like arsenic, tin, and lead, creating a “chemical cocktail” that may raise respiratory health risks for bystanders. The researchers urge treating vaping emissions like secondhand smoke and reducing indoor exposure, aligning with global policy debates and bans on vaping.
For the first time in Great Britain, more adults use vapes than smoke cigarettes, with 5.4 million vaping compared to 4.9 million smoking, reflecting a decline in smoking rates and rising vaping popularity, especially among younger adults. Health experts acknowledge vaping as less harmful than smoking but caution about potential risks, especially for children and non-smokers. The government is implementing new regulations to restrict sales and marketing of vaping products to protect youth, amid ongoing efforts to reduce smoking-related deaths.
A study by UC Riverside found that heating e-cigarette fluids produces toxic chemicals, methylglyoxal and acetaldehyde, which can damage human lung cells, with methylglyoxal being potentially more harmful even at lower levels, raising concerns about long-term health risks of vaping.
A large study suggests that vaping increases the risk of prediabetes, especially when combined with traditional smoking, highlighting potential long-term health risks beyond lung issues.
The FDA has authorized Juul to continue selling its e-cigarettes and refill cartridges, citing that the products are appropriate for the protection of public health, especially as an alternative for adults switching from cigarettes. This decision follows a lengthy review process and marks a significant development in vaping regulation, despite ongoing concerns about youth usage and health risks.
Juul has received FDA approval to sell its original e-cigarettes with tobacco and menthol flavors in the U.S., marking a significant milestone for the company amid ongoing debates over youth vaping and public health concerns.
A study in mice found that in utero exposure to certain vape liquids, even without nicotine, can cause changes in skull shape and reduce weight, raising concerns about the safety of nicotine-free e-cigarette products during pregnancy.